Cardiovascular Diseases Clinical Trial
Official title:
SYNTAX III REVOLUTION Trial: A Randomized Study to Evaluate the Feasibility of Heart-Team Clinical Decision Making Regarding the Optimal (Surgical or Percutaneous Based) Revascularization Strategy in Patients With Complex Coronary Artery Disease, Based on Non-invasive Coronary CT Angiography (CTA) Imaging Utilising High-definition GE RevolutionTM Multi-slice CT and HeartFlow FFRCT Compared to the Current Standard of Care With Conventional Invasive Coronary Angiography (CA)
The SYNTAX III Revolution trial is a randomized diagnostic research study that investigates
the use of CT scan and angiogram of the heart to help doctors decide which method is the best
to improve blood supply to the heart in patients with complex coronary artery disease. Each
patient will undergo an angiogram and CT scan per standard of care. The randomization
strategy in this study is not between patients but between two teams of doctors, the
so-called "Heart Teams", will be randomized: in the first round, team 1 assesses the
angiogram, and team 2 assesses the CT scan. Then they make a decision about which treatment
would be the best to treat complex coronary artery disease. In the second round, both teams
see the imaging method that they did not see in the first round, and make the decision again.
The final decision on the clinical treatment strategy is at the sole discretion of the Heart
Team and there are no criteria described in SYNTAXIII Revolution protocol leading influencing
this final decision.
Hypothesis: Determination of the best treatment strategy for coronary artery disease based on
a CT scan will result in similar decisions as based on invasive coronary angiography.
The SYNTAX III REVOLUTION Trial is a multicenter, all-comers trial (either isolated
unprotected left-main or 3-vessel disease with or without left-main disease and candidate for
either CABG or PCI treatment). In SYNTAXIII REVOLUTION a diagnostic coronary angiography and
a diagnostic coronary Multislice CT are performed to allow the Heart Team to assess the
optimal revascularization strategy. In a normal hospital setting the angiography is
considered standard of care. The multislice CT can already also be part of the diagnosis and
is at the discretion of the physician. After the images of both modalities are available, the
patient will no longer participate in the trial. Next step is randomization of Heart Team A
and Heart B to the sequence of availability of images, i.e. randomizing whether Heart Team A
will review the angiography first or the multislice CT and, automatically, Heart B the other
modality. The Heart Teams need to make a decision between surgical or percutaneous treatment
according to either the conventional angiography or the multislice CT angiography assessment.
In addition, the incremental value of FFRCT in the decision making of the Heart Team arm
allocated primarily to the assessment of the MSCT (CT first algorithm) will be a secondary
endpoint. No intervention to the patient's treatment takes place
i
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|